Center/Research Area Affiliations
Dr. Miller maintains an active research program in addition to his strong clinical retina practice. As a clinician scientist, his work focuses both on clinical research and the basic mechanisms of retinal disease through study in the laboratory. In the Mass. Eye and Ear Angiogenesis Laboratory, he has explored the mechanisms of retinal toxicity of systemic medications. Ongoing work explores the pathogenesis of age-related macular degeneration, macular telangiectasia, macular hole, and drug retinal toxicities.
His clinical research includes age-related macular degeneration, traumatic macular holes, and macular telangiectasia. He maintains a particular focus on retinal imaging devices, including Swept Source OCT (investigational). With additional advances in retinal imaging, he hopes to provide earlier detection of disease or predisposing factors, better prognostic information, and disease maintenance.
Dr. Miller has received multiple investigator awards, including those from top subspecialty societies: the Retina Society and Macula Society.
He maintains a close association with the latest developments in both diagnostics and therapeutics through regular attendance at subspecialty meetings, including the Retina Society, the American Society of Retina Specialists (ASRS), Association of Research in Vision and Ophthalmology (ARVO), and the Vit Buckle Society (VBS). He serves on the education committee of the Vit Buckle Society, striving to improve the surgical techniques of others through collaboration.
Finn AP, Eliott D, Kim LA, Husain D, Wu DM, Young LH, Kim IK, Andreoli C, Skondra D, Vavvas DG, Miller JB. Characteristics and Outcomes of Simultaneous Bilateral Rhegmatogenous Retinal Detachments. OSLI Retina. Accepted July 2016, in press.
Miller JB, Yonekawa Y, Eliott D, Kim IK, Kim LA, Loewenstein JI, Sobrin L, Young LH, Mukai S, and Vavvas DG. Long-term Follow-up and Outcomes in Traumatic Macular Holes. Under revision with American Journal of Ophthalmology.
Miller JB, Papakostas TD, Vavvas DG. Complications of emulsified silicone oil after retinal detachment repair. Semin Ophthalmol. 2014 Sep-Nov; 29 (5-6):312-8.
Miller JB, Kim LA, Wu DM, Vavvas DG, Eliott D, Husain D. Ocriplasmin (Jetrea®) for stage 2 macular holes: early clinical results. OSLI Retina. 2014 Jul 1;45 (4):293-7.
Peacock ZS, Boulos T, Miller JB, Gardiner MF, Chuang SK, Troulis MJ. Orbital fractures and ocular injuries: Is a postoperative ophthalmology exam necessary? J Oral Maxillofac Surg. 2014 Mar 24.
Miller JB, Yonekawa Y, Eliott D, Vavvas DG. A review of traumatic macular hole: diagnosis and treatment. Int Ophthalmol Clin, 2013 Fall; 53(4): 59-67.
Yonekawa Y, Andreoli C, Miller JB, Loewenstein JI, Sobrin L, Eliott D, Vavvas DG, Miller JW, Kim IK. Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration. Am J Ophthalmol, 2013 May 10.
View a complete list of publications on pubmed.gov »